TG Therapeutics
TGTX
TGTX
244 hedge funds and large institutions have $2.19B invested in TG Therapeutics in 2023 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 73 increasing their positions, 72 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 72
5.65% less ownership
Funds ownership: 64.81% → 59.17% (-5.6%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
244
Holding in Top 10
3
Calls
$144M
Puts
$97.6M
Top Buyers
| 1 | +$40.4M | |
| 2 | +$26.5M | |
| 3 | +$22.3M | |
| 4 |
D.E. Shaw & Co
New York
|
+$18.4M |
| 5 |
Man Group
London,
United Kingdom
|
+$17.1M |
Top Sellers
| 1 | -$76.7M | |
| 2 | -$50.1M | |
| 3 | -$44.5M | |
| 4 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$29.1M |
| 5 |
Alkeon Capital Management
New York
|
-$28.4M |